{"cdcTestId":"2013-0259","testcaseName":"dose 2 to 3 Pediarix, interval 8 weeks-4 days ","vaccineGroup":"HepB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-04T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-06-28T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-28T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-06-28T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-28T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:14:38.403","generalDescription":"This test case describes when dose #3 of the HepB vaccine (Pediarix) is administered at an interval of 8 weeks - 4 days that the dose is considered to be valid. The series is complete.","changedInVersion":"1.0","reasonForChange":""}